Cargando…
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Background: COVID-19–related critical illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in making decis...
Ejemplares similares
-
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
por: Cuker, Adam, et al.
Publicado: (2022) -
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
por: Cuker, Adam, et al.
Publicado: (2021) -
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
por: Cuker, Adam, et al.
Publicado: (2022) -
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
por: Cuker, Adam, et al.
Publicado: (2022) -
Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer
por: Rada, Gabriel, et al.
Publicado: (2013)